| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9844 |
| Human Intestinal Absorption | HIA+ | 0.9944 |
| Caco-2 Permeability | Caco2+ | 0.6161 |
| P-glycoprotein Substrate | Non-substrate | 0.7214 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.7183 |
| Non-inhibitor | 0.8907 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9207 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8693 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8987 |
| CYP450 2D6 Substrate | Non-substrate | 0.9069 |
| CYP450 3A4 Substrate | Non-substrate | 0.6639 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7539 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8885 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9310 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8446 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9253 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7783 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9679 |
| Non-inhibitor | 0.9062 |
| AMES Toxicity | Non AMES toxic | 0.9528 |
| Carcinogens | Carcinogens | 0.6969 |
| Fish Toxicity | High FHMT | 0.5673 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.8608 |
| Honey Bee Toxicity | High HBT | 0.7471 |
| Biodegradation | Ready biodegradable | 0.9578 |
| Acute Oral Toxicity | III | 0.7985 |
| Carcinogenicity (Three-class) | Non-required | 0.5187 |